Last reviewed · How we verify
PUR3100
At a glance
| Generic name | PUR3100 |
|---|---|
| Sponsor | Pulmatrix Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PUR3100 CI brief — competitive landscape report
- PUR3100 updates RSS · CI watch RSS
- Pulmatrix Inc. portfolio CI